Search - tctmd.com

Displaying 181 - 200 of 268

Sort: Relevancy | Date

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation ESC 2014

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Presenter: Petr Widimsky

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Daily News

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

L.A. McKeown

August 20, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

News Daily News

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

August 07, 2014

News Daily News

La TCO Ayuda a Identificar a Pacientes SCA Aptos para Recibir un Stent

August 07, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Leah Lawrence

July 03, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

Presentation

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Presenter: Dimitrios Alexopoulos

April 09, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

Advertisement

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

La TCO Ayuda a Identificar a Pacientes SCA Aptos para Recibir un Stent

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content